Thomas Allison

Thomas J.
Allison is currently Independent Director at Virtus Pharmaceuticals LLC since 2022, Independent Director at Grupo HIMA-San Pablo, Inc. since 2021, Lead Independent Director at Damping Technologies, Inc. since 2023, Director at Monroe Capital Income Plus Corp.
since 2022, Independent Director at Horizon Technology Finance Corp.
starting 2026, and Principal at Mr. Allison & Associates LLC since 2013.
Former roles include Chief Executive Officer at MacKeyser Holdings LLC, Chief Executive Officer & Director at American Optical Services, Inc. from 2014 to 2015, Chairman at IBC Group, Inc. from 2007 to 2013, Chairman at Turnaround Management Association, Chairman at Association of Certified Turnaround Professionals, Inc., Chairman at Phoenixus AG from 2022 to 2023, Director at KII Liquidating, Inc., Executive VP & Senior Managing Director at Mesirow Financial Holdings, Inc. from 2006 to 2012, Director at The NORDAM Group LLC from 2018 to 2019, Director at PGHC Holdings, Inc. from 2018 to 2019, Director at Silver Airways Corp.
from 2015 to 2016, Director at RockPile Energy Services LLC in 2016, Lead Director at American Direct Procurement LLC in 2024, Independent Director at Assertio Holdings, Inc., Director at Katy Industries, Inc. from 2016 to 2018, Director at NORDAM Group, Inc. from 2018 to 2019, Director at PTC Group Holdings Corp.
from 2015 to 2019, Director at Novum Pharma LLC from 2019 to 2020, Independent Director at Cannatrac Technology, Inc. from 2018 to 2020, Independent Director at MCAP Acquisition Corp.
in 2021, Independent Director at Monroe Capital Corp.
from 2013 to 2026, Interim Chief Financial Officer at FPA Medical Management, Inc., President at Forge Group Ltd. in 2014, Partner at Arthur Andersen LLP from 1988 to 2002, and Chief Restructuring Officer at Inspirion Delivery Sciences LLC from 2019 to 2020.
Education includes undergraduate and MBAistration degrees from DePaul University.